Stephen George Dilly, President and CEO at Aimmune Therapeutics, Inc. (AIMT), sold 49,400 shares at $20.21 ($998K) on 2017-06-23, disclosed to the SEC on 2017-06-27.
Open-market sale of $998k AIMT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-20 | $210K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |